, Tracking Stock Market Picks
Enter Symbol:

down 30.41 %

ALLSCRIPTS HEALTHC (MDRX) rated Buy with price target $25 by Auriga

Posted on: Monday,  Feb 20, 2012  8:25 AM ET by Auriga

Auriga rated Buy ALLSCRIPTS HEALTHC (NASDAQ: MDRX) on 02/20/2012. Previously Auriga rated Buy ALLSCRIPTS HEALTHC (NASDAQ: MDRX) on 08/03/2011., when
the stock price was $19.66. Since then, ALLSCRIPTS HEALTHC has lost 30.42% as of 01/22/2016's recent price of $13.68.
If you would have followed the previous Auriga's recommendation on MDRX, you would have lost 30.41% of your investment in 1633 days.

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), formerly Allscripts Healthcare Solutions, Inc., is a provider of clinical software, services, information and connectivity solutions used by the physicians and other health care providers. The Company?s businesses provide solutions that inform physicians with just right, just in time information, connect physicians to each other and to the entire community of care, and transforming healthcare. Allscripts provide various clinical software applications, including Electronic Health Records (EHR), practice management, revenue cycled management, clearinghouse services, electronic prescribing, Emergency Department Information System (EDIS), hospital care management and discharge management solutions, document imaging solutions, and a range of solutions for home care and other post-acute facilities. The Company operates in two business segments: clinical solutions and health solutions.

Auriga operates full-service institutional equity and fixed income trading desks with state-of-the-art communications technology and trading systems. Through our U.S. corprate parent, Auriga Holdings, LLC we offer a variety of services including whole loan trading and asset management. Through our Spanish parent company, Auriga Securities Sociedad de Valores, S.A., we offer the ability to trade European equity and fixed income products. We connect electronically to buy-side firms; route orders to multiple points of execution and subsequently route to our clearing firm, Pershing, for settlement.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/20/2012 8:25 AM Buy
19.65 25.00
as of 12/31/2012
1 Week up  1.21 %
1 Month down  -17.35 %
3 Months down  -26.00 %
1 YTD down  -51.47 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/17/2012 10:25 AM Buy
20.09 25.00
8/3/2011 8:25 AM Buy
19.66 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy